584 related articles for article (PubMed ID: 25345863)
1. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
[TBL] [Abstract][Full Text] [Related]
2. Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.
Hayes JM; Frostell A; Karlsson R; Müller S; Martín SM; Pauers M; Reuss F; Cosgrave EF; Anneren C; Davey GP; Rudd PM
Mol Cell Proteomics; 2017 Oct; 16(10):1770-1788. PubMed ID: 28576848
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of Fcγ receptors influences their interaction with various IgG1 glycoforms.
Cambay F; Forest-Nault C; Dumoulin L; Seguin A; Henry O; Durocher Y; De Crescenzo G
Mol Immunol; 2020 May; 121():144-158. PubMed ID: 32222585
[TBL] [Abstract][Full Text] [Related]
4. N-linked glycan structures of the human Fcγ receptors produced in NS0 cells.
Cosgrave EF; Struwe WB; Hayes JM; Harvey DJ; Wormald MR; Rudd PM
J Proteome Res; 2013 Aug; 12(8):3721-37. PubMed ID: 23777450
[TBL] [Abstract][Full Text] [Related]
5. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
6. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.
Ahmed AA; Keremane SR; Vielmetter J; Bjorkman PJ
J Struct Biol; 2016 Apr; 194(1):78-89. PubMed ID: 26850169
[TBL] [Abstract][Full Text] [Related]
8. CD16a with oligomannose-type
Subedi GP; Barb AW
J Biol Chem; 2018 Oct; 293(43):16842-16850. PubMed ID: 30213862
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific and site directed N-glycosylation pattern of FcγRIIIa.
Zeck A; Pohlentz G; Schlothauer T; Peter-Katalinić J; Regula JT
J Proteome Res; 2011 Jul; 10(7):3031-9. PubMed ID: 21561106
[TBL] [Abstract][Full Text] [Related]
10. Impact of N-glycosylation on Fcγ receptor / IgG interactions: unravelling differences with an enhanced surface plasmon resonance biosensor assay based on coiled-coil interactions.
Cambay F; Henry O; Durocher Y; De Crescenzo G
MAbs; 2019 Apr; 11(3):435-452. PubMed ID: 30822189
[TBL] [Abstract][Full Text] [Related]
11. Role of
Van Coillie J; Schulz MA; Bentlage AEH; de Haan N; Ye Z; Geerdes DM; van Esch WJE; Hafkenscheid L; Miller RL; Narimatsu Y; Vakhrushev SY; Yang Z; Vidarsson G; Clausen H
Front Immunol; 2022; 13():987151. PubMed ID: 36189205
[TBL] [Abstract][Full Text] [Related]
12. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity.
Thomann M; Schlothauer T; Dashivets T; Malik S; Avenal C; Bulau P; Rüger P; Reusch D
PLoS One; 2015; 10(8):e0134949. PubMed ID: 26266936
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
14. Site-Specific Glycosylation Analysis of Murine and Human Fcγ Receptors Reveals High Heterogeneity at Conserved
Pavan CH; Abdoollah Z; Marrero Roche DE; Ryan HR; Moore E; Chandler KB
J Proteome Res; 2024 Mar; 23(3):1088-1101. PubMed ID: 38363599
[TBL] [Abstract][Full Text] [Related]
15. Impact of immune complex size and glycosylation on IgG binding to human FcγRs.
Lux A; Yu X; Scanlan CN; Nimmerjahn F
J Immunol; 2013 Apr; 190(8):4315-23. PubMed ID: 23509345
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
Caaveiro JM; Kiyoshi M; Tsumoto K
Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
[TBL] [Abstract][Full Text] [Related]
17. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
[TBL] [Abstract][Full Text] [Related]
18. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
[TBL] [Abstract][Full Text] [Related]
19. Affinity and kinetic analysis of Fcgamma receptor IIIa (CD16a) binding to IgG ligands.
Li P; Jiang N; Nagarajan S; Wohlhueter R; Selvaraj P; Zhu C
J Biol Chem; 2007 Mar; 282(9):6210-21. PubMed ID: 17202140
[TBL] [Abstract][Full Text] [Related]
20. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.
Ferrara C; Stuart F; Sondermann P; Brünker P; Umaña P
J Biol Chem; 2006 Feb; 281(8):5032-6. PubMed ID: 16330541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
